Matthijs Jv Scheltema

17PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyCancer diagnosisMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 05, 2024
Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti-tumour T-cell activation - IRE-IMMUNO study.

Bart Geboers, Matthijs J Scheltema, Jason Jung

|Oct 20, 2023
Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy.

Bart Geboers, Dennie Meijer, William Counter

|Dec 10, 2022
Median 5-year outcomes of primary focal irreversible electroporation for localised prostate cancer.

Matthijs J Scheltema, Bart Geboers, Alexandar Blazevski

|Mar 03, 2022
Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomes.

Alexandar Blazevski, William Gondoputro, Matthijs J Scheltema

|Jun 04, 2020
Focal ablation of apical prostate cancer lesions with irreversible electroporation (IRE).

Alexandar Blazevski, Amer Amin, Matthijs J Scheltema

|Jan 21, 2020
Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer.

Amer Amin, Alexandar Blazevski, James Thompson

Pageof 3

Frequent Collaborators

11 joint publications

Phillip Stricker

8 joint publications

James Thompson

5 joint publications

Alexandar Blazevski

4 joint publications

Bart Geboers